Illumina to Sequence up to 1,500 Tumor Samples for Cancer Research UK's ICGC Contribution

In addition, Illumina will also provide expression and epigenetic services to characterize transcriptomic and epigenomic changes in the tumors.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.